(Q45876151)

17 December 2017

title

IL-12 gene therapy for cancer: in synergy with other immunotherapies (English)

1 reference

17 December 2017

0 references

1 reference

6

1 reference

17 December 2017

author name string

Melero I

1

1 reference

17 December 2017

Mazzolini G

2

1 reference

17 December 2017

Narvaiza I

3

1 reference

17 December 2017

Qian C

4

1 reference

17 December 2017

Chen L

5

1 reference

17 December 2017

publication date

1 March 2001

1 reference

17 December 2017

published in

Trends in Immunology

1 reference

17 December 2017

volume

22

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

113-115

1 reference

17 December 2017

Interleukin-12: a cytokine at the interface of inflammation and immunity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901824-X

7 January 2021

Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901824-X

7 January 2021

Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901824-X

7 January 2021

Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901824-X

7 January 2021

The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901824-X

7 January 2021

Potent antitumor effects mediated by local expression of the mature form of the interferon-gamma inducing factor, interleukin-18 (IL-18).

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901824-X

7 January 2021

Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901824-X

7 January 2021

Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901824-X

7 January 2021

Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901824-X

7 January 2021

Gene transfer to liver cancer cells of B7-1 plus interleukin 12 changes immunoeffector mechanisms and suppresses helper T cell type 1 cytokine production induced by interleukin 12 alone

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901824-X

7 January 2021

Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901824-X

7 January 2021

Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901824-X

7 January 2021

Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector level

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901824-X

7 January 2021

Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901824-X

7 January 2021

10.1016/S1471-4906(00)01824-X

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

11286714

1 reference

17 December 2017